ask="0.760"
ask_size="500"
average_daily_volume="3780990"
bid="0.669"
bid_size="100"
book_value="0.168"
change="+0.040"
change_from_200_day_moving_average="0.280"
change_from_50_day_moving_average="0.205"
change_from_52_week_high="-0.109"
change_From_52_week_low="0.371"
change_in_percent="+6.616%"
close="0.651"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.204"
ebitda="-41.64M"
eps_estimate_current_year="-0.130"
eps_estimate_next_quarter="-0.030"
eps_estimate_next_year="-0.110"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.655"
high_52_weeks="0.760"
last_trade_date="3/10/2017"
last_trade_price="0.651"
last_trade_size="22050"
last_trade_time="4:00pm"
low="0.575"
low_52_weeks="0.280"
market_capitalization="167.40M"
moving_average_200_day="0.371"
moving_average_50_day="0.446"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.000"
open="0.600"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+75.499%"
percent_change_from_50_day_moving_average="+46.058%"
percent_change_from_52_week_high="-14.342%"
percent_change_from_52_week_low="+132.500%"
previous_close="0.611"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.635"
price_per_sales="2.882"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.260"
stock_exchange="NCM"
symbol="PPHM"
volume="3341541"
weeks_range_52="0.280 - 0.760"
